genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2024
Vancomycin resistance
Infectious Diseases
Phage Therapy Temporarily Held Recurrent Enterococcal Infection at Bay
Drug Discovery
Vancomycin Modified to Combat Growing Antibiotic Resistance Threat
Drug Discovery
Enanta Gets Additional $9.2M toward Biodefense Antibiotic Development
Infectious Diseases
IntelligentMDx Wins CE Mark for Group B Strep Assay on Abbott m2000 Instrument
Infectious Diseases
FDA Green-Lights Thermo Fisher Scientific’s VRE Diagnostic
News
SRI and Blanca Partner to Develop Antibiotics for Drug-Resistant Infections
News
University of British Columbia Researchers Discover Immune-Boosting Peptide
News
3M Expands Medical Diagnostics Segment with Acquisition of Acolyte Biomedica
News
PTC Receives Award for Biowarfare and Bioterrorism Antibacterials
Scroll Up